Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/30196
DC FieldValueLanguage
dc.contributor.authorVelkoska Nakova, Valentinaen_US
dc.contributor.authorKrstevska, Brankicaen_US
dc.contributor.authorVolkanovska ilijevska, Cvetankaen_US
dc.contributor.authorStevchevska Gjorgjievska, Aleksandraen_US
dc.contributor.authorMucha, Argjenten_US
dc.contributor.authorTodorovska, Biljanaen_US
dc.contributor.authorBosevski, Marijanen_US
dc.date.accessioned2024-05-17T07:07:55Z-
dc.date.available2024-05-17T07:07:55Z-
dc.date.issued2022-08-17-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/30196-
dc.description.abstractBackground Overt hypothyroidisms warrants L-T4 treatment, but treatment in subclinical hypothyroidism (ScH), especially in mild form of ScH (TSH between 4,2-10mU/l and normal free thyroxine) is unknown. Objectives To compare the presence of risk factors for atherosclerosis in patients with mild form of ScH to euthyroid subjects. Methods Prospectively 67 consecutive patients with newly diagnosed ScH, and 30 healthy subjects were recruited from the outpatient department of University clinic of endocrinology in Skopje, R. of N. Macedonia. Measurement of thyroid hormones, thyroid antibodies, blood pressure, lipids, and carotid intima media thickness (CIMT) were performed in all patients. Results Mean TSH value in ScH group was 8.71G1,9 mU/l. TSH value above 7mU/l was associated and positively correlated with symptoms of hypothyroidism. Prevalence of hypertension in ScH group was higher than the control group (35.4% vs. 13.3%, PZ0,03), with a 3.5 times higher risk for hypertension (ORZ 3,5 95%CI 1,1 – 11,4). In patients with mild form of SCH statistical significant difference in percentages of patients with arterial hypertension, hypertriglyceridemia, and values of total cholesterol/HDL-C and LDL/HDL above upper reference value were found (33.9 vs. 13.3%, 33.9 vs. 10%, 26.5 vs. 6.9%, 30.6% vs. 10.3%, respectively P ! 0.05). Mean CIMT was statistically significantly higher in ScH patients than the control group (0.61 G 0.1 vs. 0,56 G 0,1 mm, PZ0.03), but not different between the mild form of ScH and control group (PZ 0.08). Positive thyroid antibodies in the ScH group have no statistically significant influence on the CIMT. Conclusions In a small study, mild form of ScH was associated with higher risk for atherosclerosis, so these patients may benefit with L-T4 treatment.en_US
dc.language.isoenen_US
dc.publisherBioscientificaen_US
dc.relation.ispartofEndocrine Abstractsen_US
dc.subjectSubclinical hypothyroidismen_US
dc.subjectAtherosclerosisen_US
dc.subjectcarotid intima media thicknessen_US
dc.titleDoes mild form of subclinical hypothyroidism needs treatment?en_US
dc.typeProceeding articleen_US
dc.relation.conferenceESE Young Endocrinologists and Scientists (EYES) 2022en_US
dc.identifier.doi10.1530/endoabs.83.to1-
dc.identifier.urlhttp://www.endocrine-abstracts.org/ea/0083/ea0083TO1.htm-
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Files in This Item:
File Description SizeFormat 
eyes2022abstractbook.pdf872.52 kBAdobe PDFView/Open
Show simple item record

Page view(s)

43
checked on Oct 8, 2024

Download(s)

15
checked on Oct 8, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.